Piotr L Chłosta

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples and disabilityRadiation therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Accelerated MVAC Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Comparison with NLR and PLR.

|Jan 25, 2025
Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients' Data.

Łukasz Kwinta, Kamil Konopka, Krzysztof Okoń

|Jan 25, 2025
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer.

Akihiro Matsukawa, Giulio Litterio, Angelo Cormio

|Jul 26, 2024
Lower Urinary Tract Symptoms Correlate with Erectile Dysfunction and Premature Ejaculation but Not with Men's Sexual Activity: Results from a Large Population-Representative Study.

Mikolaj Przydacz, Pawel Rajwa, Sabrina De Cillis

|Jun 09, 2021
Investigation of Chromosome 1 Aberrations in the Lymphocytes of Prostate Cancer and Benign Prostatic Hyperplasia Patients by Fluorescence in situ Hybridization.

Justyna Miszczyk, Mikołaj Przydacz, Michał Zembrzuski

|Apr 08, 2017
New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer.

Piotr L Chlosta, Tomasz Golabek, Péter Nyirády

Pageof 1

Frequent Collaborators

2 joint publications

Marcin Miszczyk

2 joint publications

Krzysztof Okoń

2 joint publications

Piotr J Wysocki

1 joint publications

Giulio Litterio